Cite
785 IMPACT OF NEOADJUVANT THERAPY TIMING ON SHORT- AND LONGTERM SURVIVAL FOR GASTRIC ADENOCARCINOMA PATIENTS
MLA
Kurt S. Schultz, et al. “785 Impact of Neoadjuvant Therapy Timing on Short- and Longterm Survival for Gastric Adenocarcinoma Patients.” Gastroenterology, vol. 158, May 2020, p. S-1522. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2b13eba9a0156c4dd984c2ffdf91fc23&authtype=sso&custid=ns315887.
APA
Kurt S. Schultz, Michael R. Cassidy, Jennifer F. Tseng, David McAneny, Teviah E. Sachs, Susanna W.L. de Geus, & Sing Chau Ng. (2020). 785 Impact of Neoadjuvant Therapy Timing on Short- and Longterm Survival for Gastric Adenocarcinoma Patients. Gastroenterology, 158, S-1522.
Chicago
Kurt S. Schultz, Michael R. Cassidy, Jennifer F. Tseng, David McAneny, Teviah E. Sachs, Susanna W.L. de Geus, and Sing Chau Ng. 2020. “785 Impact of Neoadjuvant Therapy Timing on Short- and Longterm Survival for Gastric Adenocarcinoma Patients.” Gastroenterology 158 (May): S-1522. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2b13eba9a0156c4dd984c2ffdf91fc23&authtype=sso&custid=ns315887.